ArticleMolecular pharmacology2026
CXCR1 and CXCR2 display receptor bias for shared chemokine agonists.
Article in Molecular pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
G protein-coupled receptors (GPCRs) mediate diverse signaling outputs through their proximal transducers: G proteins, GPCR kinases, and β-arrestins. Although ligand bias at chemokine receptors (CKRs), where ligands for the same receptor display distinct signaling patterns, is well recognized, receptor bias, where the same agonist at different receptors yields distinct transducer engagement, remains poorly understood. We compared endogenous chemokine ligands (CXCL1, CXCL5, CXCL7, CXCL8) at the highly homologous CXCR1 and CXCR2 using biosensor assays to measure Gαi activation, β-arrestin1/2 recruitment, GPCR kinase 2/3/5/6 translocation, and receptor internalization. Our data reveal qualitatively different signaling patterns, most notably where CXCL1 acts as a G protein-biased partial agonist at CXCR1 but as a balanced full agonist at CXCR2. These signaling differences correlate with receptor internalization but not subcellular ERK activation patterns measured using compartment-specific biosensors. Collectively, our findings demonstrate receptor bias in CKR signaling, transducer activation, and compartmentalized kinase activation in translating chemokine identity into discrete functional outcomes. SIGNIFICANCE STATEMENT: Ligand bias, where different ligands for the same receptor display different signaling patterns, is now well appreciated. However, there are only a few examples of receptor bias, where the same agonist generates distinct signaling profiles at different receptors. This study used biosensors and compartmental ERK biosensors to show that shared ligands of CXCR1 and CXCR2 differentially engage G proteins, β-arrestins, and G protein-coupled receptor kinases, revealing receptor bias in CXCL1-mediated signaling that extends beyond prior characterizations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.